Evidence map›Paper›PMID 19800967›Full record

ReviewFree radical biology & medicine2010

Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis.

R-M Liu, K A Gaston Pravia

Abstract readReview
In one paragraph

Review in Free radical biology & medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 212 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
212citing papers in PubMed, 2 pooled it
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

212 citing papers in PubMed, 2 syntheses or guidelines pooled it, 460 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Epiretinal membrane prevalence in asymmetrical pseudoexfoliation glaucoma and its impact on glaucoma monitoring parameters including peripapillary vessel density.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. International journal of molecular sciences · 2025
    Article

152 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

R-M LiuDepartment of Environmental Health Sciences, School of Public Health, Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. rliu@uab.edu
K A Gaston Pravia
Alabama Department of Public Health · USUniversity of Alabama at Birmingham · US

Funding

Glutathione and Lung FibrosisR01HL088141 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LIU, RUI-MING · 2008 to 2011
$1.4M
Glutathione deficiency &immune dysfunction during agingR01ES011831 · NIEHS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LIU, RUI-MING · 2002 to 2006
$1.1M
NHLBI NIH HHS 5R01HL088141-02NHLBI NIH HHS R01 HL088141NIEHS NIH HHS ES011831NIEHS NIH HHS R01 ES011831
6 · The paper itself

Abstract

Transforming growth factor beta (TGF-beta) is the most potent and ubiquitous profibrogenic cytokine, and its expression is increased in almost all the fibrotic diseases and in experimental fibrosis models. TGF-beta increases reactive oxygen species production and decreases the concentration of glutathione (GSH), the most abundant intracellular free thiol and an important antioxidant, which mediates many of the fibrogenic effects of TGF-beta in various types of cells. A decreased GSH concentration is also observed in human fibrotic diseases and in experimental fibrosis models. Although the biological significance of GSH depletion in the development of fibrosis remains obscure, GSH and N-acetylcysteine, a precursor of GSH, have been used in clinics for the treatment of fibrotic diseases. This review summarizes recent findings in the field to address the potential mechanism whereby oxidative stress mediates fibrogenesis induced by TGF-beta and the potential therapeutic value of antioxidant treatment in fibrotic diseases.

Indexed as

Oxidative StressAnimalsAntioxidantsFibrosisGlutathioneHumansReactive Oxygen SpeciesTransforming Growth Factor betaAntioxidantsGlutathioneReactive Oxygen SpeciesTransforming Growth Factor beta

Identifiers

PMID19800967
PMCPMC2818240
OpenAlexW2086378628

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.